Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Aron Feingold - Head of Corporate Communications Sandy Macrae - CEO Mark McClung - COO Prathyusha Duraibabu - CFO Jason Fontenot - Chief Scientific Officer Rob Schott - Head of Development Bettina Cockroft - Chief Medical Officer Conference Call Participants Nicole Germino - Truist Securities Yanan Zhu - Wells Fargo Maury Raycroft - Jefferies Luca Issi - RBC Capital Aspen Mori - Bank o ...